Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


27 rue Léonard De Vinci
CP 8010 Lisses
91008 Evry Cedex

Sebia a global diagnostic company, develops, manufactures and commercializes IVD tests and analyzers dedicated cancer, diabetes and hemoglobin disorders. Sebia focuses on both agarose gel and capillary assays, and their dedicated automation, to integrate into the same routine workflow. More recently Sebia completed its Myeloma line, with two important additions, Hydrashift daratumumab, to be used with the Hydragel IF test to mitigate the DARZALEX® interference, and two new generations sFLC assays, Seralite serum and Sebia FLC kappa and lambda kits.

Exhibited At: